keto vs glp-1 Beyond Agonists: An Adaptive Ketogenic–Mediterranean Protocol to Counter Metabolic Adaptation in Obesity Management On a Keto or Carnivore

Non-diabetic users have increased from 8% of new users in 2020 to 34% in 2023

These findings may explain the reduced responsiveness to GIP observed in individuals with T2DM who may have normal or even increased secretion of GIP

These patches do not contain semaglutide, tirzepatide, or other GLP-1 drugs, and theres no clinical evidence they produce comparable appetite or weight loss effects

Regardless of the mechanism, these impairments in ENS signaling could lead to alterations in the gutbrain axis that regulate energy homeostasis, as GF mice are GLP-1 resistant, demonstrating reduced activation of brainstem neurons

Higher-risk elective patients For patients at higher risk, management should be individualized

Understanding the primary FDA-approved purpose of each medication is the easiest way to narrow down your options